Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 168 articles:
HTML format
Text format



Single Articles


    January 2016
  1. HEISE R, Amann PM, Ensslen S, Marquardt Y, et al
    Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
    PLoS One. 2016;11:e0146325.
    PubMed     Text format     Abstract available


  2. MEHTA K, Appleman L, Wang H, Tarhini AA, et al
    Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients.
    PLoS One. 2016;11:e0147153.
    PubMed     Text format     Abstract available


  3. SHEEN YS, Liao YH, Lin MH, Chiu HC, et al
    Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
    PLoS One. 2016;11:e0147431.
    PubMed     Text format     Abstract available


  4. LIU J, Shen B, Shi M, Cai J, et al
    Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study.
    PLoS One. 2016;11:e0147056.
    PubMed     Text format     Abstract available


  5. VENKATESAN N, Kanwar J, Deepa PR, Khetan V, et al
    Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
    PLoS One. 2016;11:e0146128.
    PubMed     Text format     Abstract available


  6. TIWARY S, Xu L
    FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells.
    PLoS One. 2016;11:e0147638.
    PubMed     Text format     Abstract available


  7. FAN L, Li H, Niu Y, Chen Q, et al
    Characterization and Inducing Melanoma Cell Apoptosis Activity of Mannosylerythritol Lipids-A Produced from Pseudozyma aphidis.
    PLoS One. 2016;11:e0148198.
    PubMed     Text format     Abstract available


  8. PICH C, Teiti I, Sarrabayrouse G, Gallardo F, et al
    Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity.
    PLoS One. 2016;11:e0148095.
    PubMed     Text format     Abstract available


  9. DUPRAT JP, Brechtbulh ER, Costa de Sa B, Enokihara M, et al
    Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group.
    PLoS One. 2016;11:e0148160.
    PubMed     Text format     Abstract available


  10. EIKE LM, Mauseth B, Camilio KA, Rekdal O, et al
    The Cytolytic Amphipathic beta(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma.
    PLoS One. 2016;11:e0148980.
    PubMed     Text format     Abstract available


  11. OBA J, Nakahara T, Hashimoto-Hachiya A, Liu M, et al
    CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis.
    PLoS One. 2016;11:e0149285.
    PubMed     Text format     Abstract available


  12. KRYZA D, Debordeaux F, Azema L, Hassan A, et al
    Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas.
    PLoS One. 2016;11:e0149387.
    PubMed     Text format     Abstract available


  13. HURABIELLE C, Pillebout E, Stehle T, Pages C, et al
    Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.
    PLoS One. 2016;11:e0149873.
    PubMed     Text format     Abstract available


  14. STASIAK M, Boncela J, Perreau C, Karamanou K, et al
    Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity.
    PLoS One. 2016;11:e0150226.
    PubMed     Text format     Abstract available


  15. TOIA F, Buccheri S, Anfosso A, Moschella F, et al
    Skewed Differentiation of Circulating Vgamma9Vdelta2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.
    PLoS One. 2016;11:e0149570.
    PubMed     Text format     Abstract available


  16. NEWMAN JA, Cooper CD, Roos AK, Aitkenhead H, et al
    Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding.
    PLoS One. 2016;11:e0148762.
    PubMed     Text format     Abstract available


  17. KOSZALKA P, Golunska M, Urban A, Stasilojc G, et al
    Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
    PLoS One. 2016;11:e0151420.
    PubMed     Text format     Abstract available


  18. JOHANSEN P, Andersen JD, Madsen LN, Ullum H, et al
    Pigmentary Markers in Danes - Associations with Quantitative Skin Colour, Nevi Count, Familial Atypical Multiple-Mole, and Melanoma Syndrome.
    PLoS One. 2016;11:e0150381.
    PubMed     Text format     Abstract available


  19. KABILOVA TO, Sen'kova AV, Nikolin VP, Popova NA, et al
    Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice.
    PLoS One. 2016;11:e0150751.
    PubMed     Text format     Abstract available


  20. PAPPALARDO F, Russo G, Candido S, Pennisi M, et al
    Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer.
    PLoS One. 2016;11:e0152104.
    PubMed     Text format     Abstract available


  21. KASAI S, Arakawa N, Okubo A, Shigeeda W, et al
    NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG.
    PLoS One. 2016;11:e0153181.
    PubMed     Text format     Abstract available


  22. GRECKA E, Statkiewicz M, Gorska A, Biernacka M, et al
    Prenyl Ammonium Salts - New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
    PLoS One. 2016;11:e0153633.
    PubMed     Text format     Abstract available


  23. SATO S, Murakami A, Kuwajima A, Takehara K, et al
    Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
    PLoS One. 2016;11:e0154285.
    PubMed     Text format     Abstract available


  24. HARLE A, Salleron J, Franczak C, Dubois C, et al
    Detection of BRAF Mutations Using a Fully Automated Platform and Comparison with High Resolution Melting, Real-Time Allele Specific Amplification, Immunohistochemistry and Next Generation Sequencing Assays, for Patients with Metastatic Melanoma.
    PLoS One. 2016;11:e0153576.
    PubMed     Text format     Abstract available


  25. BLOKZIJL A, Chen LE, Gustafsdottir SM, Vuu J, et al
    Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
    PLoS One. 2016;11:e0154214.
    PubMed     Text format     Abstract available


  26. SHA J, Gastman BR, Morris N, Mesinkovska NA, et al
    The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons.
    PLoS One. 2016;11:e0154915.
    PubMed     Text format     Abstract available


  27. SCHUSTER C, Akslen LA, Straume O
    Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
    PLoS One. 2016;11:e0155242.
    PubMed     Text format     Abstract available


  28. XIA Y, Li Y, Westover KD, Sun J, et al
    Inhibition of Cell Proliferation in an NRAS Mutant Melanoma Cell Line by Combining Sorafenib and alpha-Mangostin.
    PLoS One. 2016;11:e0155217.
    PubMed     Text format     Abstract available


  29. KESKINOV AA, Tapias V, Watkins SC, Ma Y, et al
    Impact of the Sensory Neurons on Melanoma Growth In Vivo.
    PLoS One. 2016;11:e0156095.
    PubMed     Text format     Abstract available


  30. GUGGER A, Barnhill RL, Seifert B, Dehler S, et al
    Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations.
    PLoS One. 2016;11:e0156115.
    PubMed     Text format     Abstract available


  31. MAEKAWA N, Konnai S, Okagawa T, Nishimori A, et al
    Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma.
    PLoS One. 2016;11:e0157176.
    PubMed     Text format     Abstract available


  32. MARQUES CM, MacNeil S
    Use of a Tissue Engineered Human Skin Model to Investigate the Effects of Wounding and of an Anti-Inflammatory on Melanoma Cell Invasion.
    PLoS One. 2016;11:e0156931.
    PubMed     Text format     Abstract available


  33. NATH K, Nelson DS, Putt ME, Leeper DB, et al
    Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    PLoS One. 2016;11:e0157125.
    PubMed     Text format     Abstract available


  34. TALAR B, Gajos-Michniewicz A, Talar M, Chouaib S, et al
    Pentoxifylline Inhibits WNT Signalling in beta-Cateninhigh Patient-Derived Melanoma Cell Populations.
    PLoS One. 2016;11:e0158275.
    PubMed     Text format     Abstract available


  35. MUN JH, Ohn J, Kim WI, Park SM, et al
    Dermoscopy of Melanomas on the Trunk and Extremities in Asians.
    PLoS One. 2016;11:e0158374.
    PubMed     Text format     Abstract available


  36. HUANG Q, Wei H, Wu Z, Li L, et al
    Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis.
    PLoS One. 2016;11:e0149640.
    PubMed     Text format     Abstract available


  37. GROSSI MARCONI D, da Costa Resende B, Rauber E, de Cassia Soares P, et al
    Head and Neck Non-Melanoma Skin Cancer Treated By Superficial X-Ray Therapy: An Analysis of 1021 Cases.
    PLoS One. 2016;11:e0156544.
    PubMed     Text format     Abstract available


  38. DORAN CM, Ling R, Byrnes J, Crane M, et al
    Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia.
    PLoS One. 2016;11:e0147665.
    PubMed     Text format     Abstract available


  39. KICIELINSKA J, Szczygiel A, Rossowska J, Anger N, et al
    Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models.
    PLoS One. 2016;11:e0148156.
    PubMed     Text format     Abstract available


  40. FROUIN E, Maudelonde T, Senal R, Larrieux M, et al
    Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens.
    PLoS One. 2016;11:e0158698.
    PubMed     Text format     Abstract available


  41. AZZARITO T, Lugini L, Spugnini EP, Canese R, et al
    Effect of Modified Alkaline Supplementation on Syngenic Melanoma Growth in CB57/BL Mice.
    PLoS One. 2016;11:e0159763.
    PubMed     Text format     Abstract available


  42. VEDEL-KROGH S, Nielsen SF, Schnohr P, Nordestgaard BG, et al
    Morbidity and Mortality in 7,684 Women According to Personal Hair Dye Use: The Copenhagen City Heart Study followed for 37 Years.
    PLoS One. 2016;11:e0151636.
    PubMed     Text format     Abstract available


  43. YUAN P, Cao JL, Abuduwufuer A, Wang LM, et al
    Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
    PLoS One. 2016;11:e0146803.
    PubMed     Text format     Abstract available


  44. LIN Z, Chen X, Li Z, Luo Y, et al
    PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0160485.
    PubMed     Text format     Abstract available


  45. LIMM K, Dettmer K, Reinders J, Oefner PJ, et al
    Characterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954 - Incidence and Effects on Enzymatic Function in Malignant Melanoma.
    PLoS One. 2016;11:e0160348.
    PubMed     Text format     Abstract available


  46. HACKLER L JR, Ozsvari B, Gyuris M, Sipos P, et al
    The Curcumin Analog C-150, Influencing NF-kappaB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo.
    PLoS One. 2016;11:e0149832.
    PubMed     Text format     Abstract available


  47. YAMAMOTO M, Zhao M, Hiroshima Y, Zhang Y, et al
    Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model.
    PLoS One. 2016;11:e0160882.
    PubMed     Text format     Abstract available


  48. MUN JH, Ohn J, Kim WI, Park SM, et al
    Correction: Dermoscopy of Melanomas on the Trunk and Extremities in Asians.
    PLoS One. 2016;11:e0161419.
    PubMed     Text format     Abstract available


  49. ELISIA I, Nakamura H, Lam V, Hofs E, et al
    DMSO Represses Inflammatory Cytokine Production from Human Blood Cells and Reduces Autoimmune Arthritis.
    PLoS One. 2016;11:e0152538.
    PubMed     Text format     Abstract available


  50. LUTZ NW, Banerjee P, Wilson BJ, Ma J, et al
    Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
    PLoS One. 2016;11:e0161803.
    PubMed     Text format     Abstract available


  51. MALO CS, Renner DN, Huseby Kelcher AM, Jin F, et al
    The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma.
    PLoS One. 2016;11:e0162064.
    PubMed     Text format     Abstract available


  52. DASHTSOODOL N, Shigeura T, Ozawa R, Harada M, et al
    Generation of Novel Traj18-Deficient Mice Lacking Valpha14 Natural Killer T Cells with an Undisturbed T Cell Receptor alpha-Chain Repertoire.
    PLoS One. 2016;11:e0153347.
    PubMed     Text format     Abstract available


  53. ALARI-PAHISSA E, Grandclement C, Jeevan-Raj B, Leclercq G, et al
    Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition.
    PLoS One. 2016;11:e0153236.
    PubMed     Text format     Abstract available


  54. WU L, Hu Z, Huang Y, Yu Y, et al
    Radiation Changes the Metabolic Profiling of Melanoma Cell Line B16.
    PLoS One. 2016;11:e0162917.
    PubMed     Text format     Abstract available


  55. JIANG F, Jin K, Huang S, Bao Q, et al
    Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells.
    PLoS One. 2016;11:e0159849.
    PubMed     Text format     Abstract available


  56. LE TT, Skak K, Schroder K, Schroder WA, et al
    IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
    PLoS One. 2016;11:e0153975.
    PubMed     Text format     Abstract available


  57. GONZALES C, Yoshihara HA, Dilek N, Leignadier J, et al
    In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI.
    PLoS One. 2016;11:e0164557.
    PubMed     Text format     Abstract available


  58. VAN ESSEN TH, van Pelt SI, Bronkhorst IH, Versluis M, et al
    Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.
    PLoS One. 2016;11:e0164292.
    PubMed     Text format     Abstract available


  59. MISHRA PJ, Mishra PJ, Merlino G
    Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
    PLoS One. 2016;11:e0165102.
    PubMed     Text format     Abstract available


  60. YU J, Luo X, Huang H, Zhai Z, et al
    Clinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported Cases.
    PLoS One. 2016;11:e0165591.
    PubMed     Text format     Abstract available


    January 2015
  61. MARTIN DEL CAMPO SE, Latchana N, Levine KM, Grignol VP, et al
    MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor.
    PLoS One. 2015;10:e0115919.
    PubMed     Text format     Abstract available


  62. BEUTEL ME, Fischbeck S, Binder H, Blettner M, et al
    Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma: A Register-Based Cohort Study.
    PLoS One. 2015;10:e0116440.
    PubMed     Text format     Abstract available


  63. RIBERO S, Glass D, Aviv A, Spector TD, et al
    Height and bone mineral density are associated with naevus count supporting the importance of growth in melanoma susceptibility.
    PLoS One. 2015;10:e0116863.
    PubMed     Text format     Abstract available


  64. MORETTI D, Del Bello B, Allavena G, Corti A, et al
    Calpain-3 Impairs Cell Proliferation and Stimulates Oxidative Stress-Mediated Cell Death in Melanoma Cells.
    PLoS One. 2015;10:e0117258.
    PubMed     Text format     Abstract available


  65. GARAY T, Kenessey I, Molnar E, Juhasz E, et al
    Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells.
    PLoS One. 2015;10:e0117021.
    PubMed     Text format     Abstract available


  66. PERETZ Y, Wu H, Patel S, Bellacosa A, et al
    Inhibitor of DNA Binding 4 (ID4) Is Highly Expressed in Human Melanoma Tissues and May Function to Restrict Normal Differentiation of Melanoma Cells.
    PLoS One. 2015;10:e0116839.
    PubMed     Text format     Abstract available


  67. KATOH D, Nishizuka M, Osada S, Imagawa M, et al
    Fad104, a Positive Regulator of Adipocyte Differentiation, Suppresses Invasion and Metastasis of Melanoma Cells by Inhibition of STAT3 Activity.
    PLoS One. 2015;10:e0117197.
    PubMed     Text format     Abstract available


  68. CHIEN CH, Lee MJ, Liou HC, Liou HH, et al
    Local Immunosuppressive Microenvironment Enhances Migration of Melanoma Cells to Lungs in DJ-1 Knockout Mice.
    PLoS One. 2015;10:e0115827.
    PubMed     Text format     Abstract available


  69. FAIAO-FLORES F, Quincoces Suarez JA, Fruet AC, Maria-Engler SS, et al
    Curcumin Analog DM-1 in Monotherapy or Combinatory Treatment with Dacarbazine as a Strategy to Inhibit In Vivo Melanoma Progression.
    PLoS One. 2015;10:e0118702.
    PubMed     Text format     Abstract available



  70. Correction: Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation.
    PLoS One. 2015;10:e0118728.
    PubMed     Text format     Abstract available


  71. VERSLUIS M, de Lange MJ, van Pelt SI, Ruivenkamp CA, et al
    Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma.
    PLoS One. 2015;10:e0116371.
    PubMed     Text format     Abstract available


  72. ZIMMER L, Vaubel J, Mohr P, Hauschild A, et al
    Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naive Patients with Metastatic Uveal Melanoma.
    PLoS One. 2015;10:e0118564.
    PubMed     Text format     Abstract available


  73. BRONCHALO-VICENTE L, Rodriguez-Del Rio E, Freire J, Calderon-Gonzalez R, et al
    A Novel Therapy for Melanoma Developed in Mice: Transformation of Melanoma into Dendritic Cells with Listeria monocytogenes.
    PLoS One. 2015;10:e0117923.
    PubMed     Text format     Abstract available


  74. PFARR K, Danciu C, Arlt O, Neske C, et al
    Simultaneous and dose dependent melanoma cytotoxic and immune stimulatory activity of betulin.
    PLoS One. 2015;10:e0118802.
    PubMed     Text format     Abstract available


  75. TAYLOR NJ, Busam KJ, From L, Groben PA, et al
    Inherited Variation at MC1R and Histological Characteristics of Primary Melanoma.
    PLoS One. 2015;10:e0119920.
    PubMed     Text format     Abstract available


  76. MOURAH S, Denis MG, Narducci FE, Solassol J, et al
    Detection of BRAF V600 Mutations in Melanoma: Evaluation of Concordance between the Cobas(R) 4800 BRAF V600 Mutation Test and the Methods Used in French National Cancer Institute (INCa) Platforms in a Real-Life Setting.
    PLoS One. 2015;10:e0120232.
    PubMed     Text format     Abstract available


  77. KOCARNIK JM, Park SL, Han J, Dumitrescu L, et al
    Pleiotropic and Sex-Specific Effects of Cancer GWAS SNPs on Melanoma Risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.
    PLoS One. 2015;10:e0120491.
    PubMed     Text format     Abstract available


  78. REN S, Chai L, Wang C, Li C, et al
    Human malignant melanoma-derived progestagen-associated endometrial protein immunosuppresses T lymphocytes in vitro.
    PLoS One. 2015;10:e0119038.
    PubMed     Text format     Abstract available


  79. VALPIONE S, Moser JC, Parrozzani R, Bazzi M, et al
    Development and external validation of a prognostic nomogram for metastatic uveal melanoma.
    PLoS One. 2015;10:e0120181.
    PubMed     Text format     Abstract available


  80. GENG P, Liao Y, Ruan Z, Liang H, et al
    Increased Risk of Cutaneous Melanoma Associated with p53 Arg72Pro Polymorphism.
    PLoS One. 2015;10:e0118112.
    PubMed     Text format     Abstract available


  81. BAI J, Lei Y, An GL, He L, et al
    Down-Regulation of Deacetylase HDAC6 Inhibits the Melanoma Cell Line A375.S2 Growth through ROS-Dependent Mitochondrial Pathway.
    PLoS One. 2015;10:e0121247.
    PubMed     Text format     Abstract available


  82. HAN D, Han G, Zhao X, Rao NG, et al
    Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma.
    PLoS One. 2015;10:e0119716.
    PubMed     Text format     Abstract available


  83. XU MJ, Cooke M, Steinmetz D, Karakousis G, et al
    A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells.
    PLoS One. 2015;10:e0123376.
    PubMed     Text format     Abstract available


  84. WADT KA, Aoude LG, Krogh L, Sunde L, et al
    Molecular characterization of melanoma cases in denmark suspected of genetic predisposition.
    PLoS One. 2015;10:e0122662.
    PubMed     Text format     Abstract available


  85. JENKINS MH, Brinckerhoff CE, Mullins DW
    CXCR3 Signaling in BRAFWT Melanoma Increases IL-8 Expression and Tumorigenicity.
    PLoS One. 2015;10:e0121140.
    PubMed     Text format     Abstract available


  86. KREISEDER B, Holper-Schichl YM, Muellauer B, Jacobi N, et al
    Alpha-Catulin Contributes to Drug-Resistance of Melanoma by Activating NF-kappaB and AP-1.
    PLoS One. 2015;10:e0119402.
    PubMed     Text format     Abstract available



  87. Correction: Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation.
    PLoS One. 2015;10:e0122943.
    PubMed     Text format     Abstract available


  88. ARTS N, Cane S, Hennequart M, Lamy J, et al
    microRNA-155, Induced by Interleukin-1ss, Represses the Expression of Microphthalmia-Associated Transcription Factor (MITF-M) in Melanoma Cells.
    PLoS One. 2015;10:e0122517.
    PubMed     Text format     Abstract available


  89. GOWRISHANKAR K, Gunatilake D, Gallagher SJ, Tiffen J, et al
    Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-kappaB.
    PLoS One. 2015;10:e0123410.
    PubMed     Text format     Abstract available


  90. BARTLETT D, Boyle GM, Ziman M, Medic S, et al
    Mechanisms Contributing to Differential Regulation of PAX3 Downstream Target Genes in Normal Human Epidermal Melanocytes versus Melanoma Cells.
    PLoS One. 2015;10:e0124154.
    PubMed     Text format     Abstract available


  91. RAUSCH MP, Hastings KT
    An Exhaustion-Like Phenotype Constrains the Activity of CD4+ T Cells Specific for a Self and Melanoma Antigen.
    PLoS One. 2015;10:e0123332.
    PubMed     Text format     Abstract available


  92. MOLOGNONI F, de Melo FH, da Silva CT, Jasiulionis MG, et al
    Correction: Ras and Rac1, Frequently Mutated in Melanomas, Are Activated by Superoxide Anion, Modulate Dnmt1 Level and Are Causally Related to Melanocyte Malignant Transformation.
    PLoS One. 2015;10:e0124983.
    PubMed     Text format     Abstract available


  93. WELINDER C, Pawlowski K, Sugihara Y, Yakovleva M, et al
    A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues.
    PLoS One. 2015;10:e0123661.
    PubMed     Text format     Abstract available


  94. MARQUEZ-RODAS I, Martin Gonzalez M, Nagore E, Gomez-Fernandez C, et al
    Frequency and Characteristics of Familial Melanoma in Spain: The FAM-GEM-1 Study.
    PLoS One. 2015;10:e0124239.
    PubMed     Text format     Abstract available


  95. WANG Y, Lv J, Cheng Y, Du J, et al
    Apoptosis Induced by Ginkgo biloba (EGb761) in Melanoma Cells Is Mcl-1-Dependent.
    PLoS One. 2015;10:e0124812.
    PubMed     Text format     Abstract available


  96. CURL P, Vujic I, van 't Veer LJ, Ortiz-Urda S, et al
    Correction: Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma.
    PLoS One. 2015;10:e0126988.
    PubMed     Text format     Abstract available


  97. ATKINSON JM, Rank KB, Zeng Y, Capen A, et al
    Activating the Wnt/beta-Catenin Pathway for the Treatment of Melanoma - Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
    PLoS One. 2015;10:e0125028.
    PubMed     Text format     Abstract available


  98. ROSSI AH, Farias A, Fernandez JE, Bonomi HR, et al
    Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.
    PLoS One. 2015;10:e0126827.
    PubMed     Text format     Abstract available


  99. WYATT C, Lucas RM, Hurst C, Kimlin MG, et al
    Vitamin d deficiency at melanoma diagnosis is associated with higher breslow thickness.
    PLoS One. 2015;10:e0126394.
    PubMed     Text format     Abstract available


  100. SUN L, Bian G, Meng Z, Dang G, et al
    MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.
    PLoS One. 2015;10:e0124428.
    PubMed     Text format     Abstract available


  101. KINIWA Y, Li J, Wang M, Sun C, et al
    Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells.
    PLoS One. 2015;10:e0124094.
    PubMed     Text format     Abstract available


  102. MORIARTY JP, Borah BJ, Foote RL, Pulido JS, et al
    Cost-effectiveness of proton beam therapy for intraocular melanoma.
    PLoS One. 2015;10:e0127814.
    PubMed     Text format     Abstract available


  103. RADAELLI E, Hermans E, Omodho L, Francis A, et al
    Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas.
    PLoS One. 2015;10:e0124974.
    PubMed     Text format     Abstract available


  104. HARTMAN ML, Talar B, Gajos-Michniewicz A, Czyz M, et al
    MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.
    PLoS One. 2015;10:e0128796.
    PubMed     Text format     Abstract available


  105. VAMAN V S A, Poppe H, Houben R, Grunewald TG, et al
    LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression.
    PLoS One. 2015;10:e0129219.
    PubMed     Text format     Abstract available


  106. PAOLONI M, Mazcko C, Selting K, Lana S, et al
    Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma.
    PLoS One. 2015;10:e0129954.
    PubMed     Text format     Abstract available


  107. CARBOGNIN L, Pilotto S, Milella M, Vaccaro V, et al
    Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
    PLoS One. 2015;10:e0130142.
    PubMed     Text format     Abstract available


  108. FUKUDA K, Sugihara E, Ohta S, Izuhara K, et al
    Periostin Is a Key Niche Component for Wound Metastasis of Melanoma.
    PLoS One. 2015;10:e0129704.
    PubMed     Text format     Abstract available


  109. SHEN J, Gopalakrishnan V, Lee JE, Fang S, et al
    Mitochondrial DNA Copy Number in Peripheral Blood and Melanoma Risk.
    PLoS One. 2015;10:e0131649.
    PubMed     Text format     Abstract available


  110. RAFIQ RA, Quadri A, Nazir LA, Peerzada K, et al
    A Potent Inhibitor of Phosphoinositide 3-Kinase (PI3K) and Mitogen Activated Protein (MAP) Kinase Signalling, Quercetin (3, 3', 4', 5, 7-Pentahydroxyflavone) Promotes Cell Death in Ultraviolet (UV)-B-Irradiated B16F10 Melanoma Cells.
    PLoS One. 2015;10:e0131253.
    PubMed     Text format     Abstract available


  111. CATTANEO L, Cicconi R, Mignogna G, Giorgi A, et al
    Anti-Proliferative Effect of Rosmarinus officinalis L. Extract on Human Melanoma A375 Cells.
    PLoS One. 2015;10:e0132439.
    PubMed     Text format     Abstract available


  112. SHAO Z, Bao Q, Jiang F, Qian H, et al
    VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo.
    PLoS One. 2015;10:e0132655.
    PubMed     Text format     Abstract available


  113. TARHINI AA, Lin Y, Zahoor H, Shuai Y, et al
    Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-alpha but Not Observation in Intermediate Risk Melanoma Patients.
    PLoS One. 2015;10:e0132745.
    PubMed     Text format     Abstract available


  114. MARZAGALLI M, Casati L, Moretti RM, Montagnani Marelli M, et al
    Estrogen Receptor beta Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.
    PLoS One. 2015;10:e0134396.
    PubMed     Text format     Abstract available


  115. MESSAOUDENE M, Perier A, Fregni G, Neves E, et al
    Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.
    PLoS One. 2015;10:e0133363.
    PubMed     Text format     Abstract available


  116. SALVATIERRA E, Alvarez MJ, Leishman CC, Rivas Baquero E, et al
    SPARC Controls Melanoma Cell Plasticity through Rac1.
    PLoS One. 2015;10:e0134714.
    PubMed     Text format     Abstract available


  117. CLAWSON GA, Matters GL, Xin P, Imamura-Kawasawa Y, et al
    Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients.
    PLoS One. 2015;10:e0134320.
    PubMed     Text format     Abstract available


  118. BHANDARU M, Martinka M, McElwee KJ, Rotte A, et al
    Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.
    PLoS One. 2015;10:e0134678.
    PubMed     Text format     Abstract available


  119. CRABB JW, Hu B, Crabb JS, Triozzi P, et al
    iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.
    PLoS One. 2015;10:e0135543.
    PubMed     Text format     Abstract available


  120. FISCHBECK S, Imruck BH, Blettner M, Weyer V, et al
    Psychosocial Care Needs of Melanoma Survivors: Are They Being Met?
    PLoS One. 2015;10:e0132754.
    PubMed     Text format     Abstract available


  121. HALDER B, Singh S, Thakur SS
    Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells.
    PLoS One. 2015;10:e0137498.
    PubMed     Text format     Abstract available


  122. MARKOV OV, Mironova NL, Sennikov SV, Vlassov VV, et al
    Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
    PLoS One. 2015;10:e0136911.
    PubMed     Text format     Abstract available


  123. DE LANGE MJ, Razzaq L, Versluis M, Verlinde S, et al
    Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.
    PLoS One. 2015;10:e0138002.
    PubMed     Text format     Abstract available


  124. MANGANA J, Cheng PF, Schindler K, Weide B, et al
    Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
    PLoS One. 2015;10:e0139438.
    PubMed     Text format     Abstract available


  125. CAPALDO BJ, Roller D, Axelrod MJ, Koeppel AF, et al
    Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma.
    PLoS One. 2015;10:e0138210.
    PubMed     Text format     Abstract available


  126. SPIESBERGER K, Paulfranz F, Egger A, Reiser J, et al
    Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle.
    PLoS One. 2015;10:e0140471.
    PubMed     Text format     Abstract available


  127. FRIEDMAN AA, Amzallag A, Pruteanu-Malinici I, Baniya S, et al
    Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
    PLoS One. 2015;10:e0140310.
    PubMed     Text format     Abstract available


  128. GALVAN DL, O'Neil RT, Foster AE, Huye L, et al
    Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model.
    PLoS One. 2015;10:e0140744.
    PubMed     Text format     Abstract available


  129. CARON JM, Caron JM
    Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells.
    PLoS One. 2015;10:e0141565.
    PubMed     Text format     Abstract available


  130. HALDER B, Singh S, Thakur SS
    Correction: Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells.
    PLoS One. 2015;10:e0141053.
    PubMed     Text format     Abstract available


  131. SHAO H, Kong R, Ferrari ML, Radtke F, et al
    Notch1 Pathway Activity Determines the Regulatory Role of Cancer-Associated Fibroblasts in Melanoma Growth and Invasion.
    PLoS One. 2015;10:e0142815.
    PubMed     Text format     Abstract available


  132. STADLER J, Eder J, Pratscher B, Brandt S, et al
    SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.
    PLoS One. 2015;10:e0142273.
    PubMed     Text format     Abstract available


  133. KAUSHIK A, Bhatia Y, Ali S, Gupta D, et al
    Gene Network Rewiring to Study Melanoma Stage Progression and Elements Essential for Driving Melanoma.
    PLoS One. 2015;10:e0142443.
    PubMed     Text format     Abstract available


  134. PYATNITSKIY M, Karpov D, Poverennaya E, Lisitsa A, et al
    Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma.
    PLoS One. 2015;10:e0142819.
    PubMed     Text format     Abstract available


  135. KUMAGAI K, Tabu K, Sasaki F, Takami Y, et al
    Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
    PLoS One. 2015;10:e0143413.
    PubMed     Text format     Abstract available


  136. LIU YM, Li Y, Wei WB, Xu X, et al
    Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
    PLoS One. 2015;10:e0144562.
    PubMed     Text format     Abstract available


  137. MIYASHITA A, Fukushima S, Nakahara S, Yamashita J, et al
    Investigation of FOXM1 as a Potential New Target for Melanoma.
    PLoS One. 2015;10:e0144241.
    PubMed     Text format     Abstract available


  138. LARKIN J, Hatswell AJ, Nathan P, Lebmeier M, et al
    The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK.
    PLoS One. 2015;10:e0145524.
    PubMed     Text format     Abstract available


  139. SCHARTL M, Shen Y, Maurus K, Walter R, et al
    Whole Body Melanoma Transcriptome Response in Medaka.
    PLoS One. 2015;10:e0143057.
    PubMed     Text format     Abstract available


  140. UZANA R, Eisenberg G, Merims S, Frankenburg S, et al
    Human T cell crosstalk is induced by tumor membrane transfer.
    PLoS One. 2015;10:e0118244.
    PubMed     Text format     Abstract available


  141. LHOUMEAU AC, Martinez S, Boher JM, Monges G, et al
    Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
    PLoS One. 2015;10:e0123768.
    PubMed     Text format     Abstract available


  142. MARTEL G, Hawel J, Rekman J, Croome KP, et al
    Liver resection for non-colorectal, non-carcinoid, non-sarcoma metastases: a multicenter study.
    PLoS One. 2015;10:e0120569.
    PubMed     Text format     Abstract available


  143. CHRISTOPHE C, Muller S, Rodrigues M, Petit AE, et al
    A biased competition theory of cytotoxic T lymphocyte interaction with tumor nodules.
    PLoS One. 2015;10:e0120053.
    PubMed     Text format     Abstract available


  144. KRIZBAI IA, Gasparics A, Nagyoszi P, Fazakas C, et al
    Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation.
    PLoS One. 2015;10:e0123845.
    PubMed     Text format     Abstract available


  145. KOLLGAARD T, Ugurel-Becker S, Idorn M, Andersen MH, et al
    Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes.
    PLoS One. 2015;10:e0131934.
    PubMed     Text format     Abstract available


  146. BEIDERWELLEN K, Geraldo L, Ruhlmann V, Heusch P, et al
    Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.
    PLoS One. 2015;10:e0137285.
    PubMed     Text format     Abstract available


    January 2014
  147. KRAMMER R, Heinzerling L
    Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls.
    PLoS One. 2014;9:e111237.
    PubMed     Text format     Abstract available


  148. DING L, Kim M, Kanchi KL, Dees ND, et al
    Clonal Architectures and Driver Mutations in Metastatic Melanomas.
    PLoS One. 2014;9:e111153.
    PubMed     Text format     Abstract available


  149. PROBST M, Hoeller C, Ferenci P, Staettermayer AF, et al
    IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma.
    PLoS One. 2014;9:e112613.
    PubMed     Text format     Abstract available


  150. MEHRA T, Grozinger G, Mann S, Guenova E, et al
    Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma.
    PLoS One. 2014;9:e112535.
    PubMed     Text format     Abstract available


  151. MOUTAI T, Yamana H, Nojima T, Kitamura D, et al
    A novel and effective cancer immunotherapy mouse model using antigen-specific B cells selected in vitro.
    PLoS One. 2014;9:e92732.
    PubMed     Text format     Abstract available


  152. SATAKE A, Schmidt AM, Nomura S, Kambayashi T, et al
    Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation.
    PLoS One. 2014;9:e92888.
    PubMed     Text format     Abstract available


  153. GARRISI VM, Strippoli S, De Summa S, Pinto R, et al
    Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation.
    PLoS One. 2014;9:e112025.
    PubMed     Text format     Abstract available


  154. BADE B, Zdebik A, Wagenpfeil S, Graber S, et al
    Low serum 25-hydroxyvitamin d concentrations are associated with increased risk for melanoma and unfavourable prognosis.
    PLoS One. 2014;9:e112863.
    PubMed     Text format     Abstract available


  155. SHAN X, Fu Y, Aziz F, Wang X, et al
    Ginsenoside Rg3 Inhibits Melanoma Cell Proliferation through Down-Regulation of Histone Deacetylase 3 (HDAC3) and Increase of p53 Acetylation.
    PLoS One. 2014;9:e115401.
    PubMed     Text format     Abstract available


  156. ONKEN MD, Li J, Cooper JA
    Uveal Melanoma Cells Utilize a Novel Route for Transendothelial Migration.
    PLoS One. 2014;9:e115472.
    PubMed     Text format     Abstract available


  157. HAGGERTY TJ, Dunn IS, Rose LB, Newton EE, et al
    Heat Shock Protein-90 Inhibitors Enhance Antigen Expression on Melanomas and Increase T Cell Recognition of Tumor Cells.
    PLoS One. 2014;9:e114506.
    PubMed     Text format     Abstract available


  158. JIANG G, Li RH, Sun C, Liu YQ, et al
    Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis.
    PLoS One. 2014;9:e111920.
    PubMed     Text format     Abstract available


  159. CARPI S, Fogli S, Giannetti A, Adinolfi B, et al
    Theranostic Properties of a Survivin-Directed Molecular Beacon in Human Melanoma Cells.
    PLoS One. 2014;9:e114588.
    PubMed     Text format     Abstract available


  160. JIANG H, Clise-Dwyer K, Ruisaard KE, Fan X, et al
    Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model.
    PLoS One. 2014;9:e97407.
    PubMed     Text format     Abstract available


  161. SINGH S, Yang G, Schluns KS, Anthony SM, et al
    Sublingual Vaccination Induces Mucosal and Systemic Adaptive Immunity for Protection against Lung Tumor Challenge.
    PLoS One. 2014;9:e90001.
    PubMed     Text format     Abstract available


  162. BEHR M, Kaufmann JK, Ketzer P, Engelhardt S, et al
    Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds.
    PLoS One. 2014;9:e95723.
    PubMed     Text format     Abstract available


  163. JOSHI S, Singh AR, Zulcic M, Bao L, et al
    Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo.
    PLoS One. 2014;9:e95893.
    PubMed     Text format     Abstract available


  164. LI J, Doyle MA, Saeed I, Wong SQ, et al
    Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment.
    PLoS One. 2014;9:e95217.
    PubMed     Text format     Abstract available


  165. WANG Y, Freemantle N, Nazareth I, Hunt K, et al
    Gender differences in survival and the use of primary care prior to diagnosis of three cancers: an analysis of routinely collected UK general practice data.
    PLoS One. 2014;9:e101562.
    PubMed     Text format     Abstract available


  166. MULLER JR, Waldmann TA, Dubois S
    Loss of cytotoxicity and gain of cytokine production in murine tumor-activated NK cells.
    PLoS One. 2014;9:e102793.
    PubMed     Text format     Abstract available


  167. DA SILVA PC, Rosembach TV, Santos AA, Rocha MS, et al
    Normal and tumoral melanocytes exhibit q-Gaussian random search patterns.
    PLoS One. 2014;9:e104253.
    PubMed     Text format     Abstract available


  168. CHEN SC, Su YC, Lu YT, Ko PC, et al
    Defects in the Acquisition of Tumor-Killing Capability of CD8+ Cytotoxic T Cells in Streptozotocin-Induced Diabetic Mice.
    PLoS One. 2014;9:e109961.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Pfizer Oncology.

Design: